EAU 2023 | Managing biochemical relapse after radical prostatectomy

Juan Gómez Rivas, MD, PhD, Clínico San Carlos University Hospital, Madrid, Spain, discusses biochemical relapse following radical prostatectomy. Biochemical recurrence occurs in approximately 25-30% of patients undergoing radical cystectomy, following which molecular imaging, particularly PSMA PET, is used to help tailor subsequent treatment options. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.